Global Hyperbaric Oxygen Therapy Devices Market 2026–2035

Reports Description

The market size of global hyperbaric oxygen therapy devices will be estimated at USD 3.89 billion in 2025 and is expected to grow to between USD 4.08 billion in 2026 and about USD 6.27 billion by 2035, with a current CAGR (compound annual growth rate) of 4.9% during the period of 2026 to 2035. Hyperbaric oxygen therapy devices are medical instruments, which provide the patient with oxygen under increased pressure, thus enabling a higher concentration of oxygen in the body than being used to normally. Such devices consist of a chamber, oxygen supply, pressure regulation modules, patient monitoring modules, ventilation system, and control modules.

Hyperbaric oxygen therapy devices are generally divided into monoplace (for single patient usage) and multiplace (for multiple patient usage) chambers. The increased pressure allows for creating the environment, where oxygen is more saturated, which in its turn improves the amount of oxygen in the tissues and is used for the treatment of decompression sickness, selected wounds, radiation tissue damage, and other diseases. The market offers a wide range of hyperbaric oxygen therapy devices, among which are the ones designed for hospital use and other more portable and less powerful devices.

To learn more about this report - request a sample report PDF

Market Highlight

• In 2025, North America will dominate the global market with an estimated market share of 32%. The growth is due to the increasing prevalence of diabetes.
• The Asia Pacific is growing at the fastest rate, driven by the growing investment in the healthcare infrastructure.
• By product, the Monoplace HBOT devices segment represented the highest revenue share in 2025 of 62%.
• By application, the wound healing segment would have the highest share of the market in 2025 of 39.6%.

Significant Growth Factors

• Rising Prevalence of Diabetes And Diabetic Foot Ulcers: Growing incidence of diabetes is a key driver behind the increasing growth rate of the hyperbaric oxygen therapy devices market. Persistently increased blood sugar levels can cause damage to the body, including neurons and blood vessels, loss of feeling, and decreased blood flow notably in the feet. In 2023, the Centers for Disease Control and Prevention (CDC) reported an estimated 40.1 million persons in the U.S. were diagnosed or undiagnosed with diabetes, or about 12% of the population. Diabetes is also the leading cause of lower extremity amputations in the U.S., the CDC added, which makes the disease and its impact on the feet even more serious. Diabetic foot ulcers are another important problem. In their lifetime, approximately 12% of diabetes people will experience a diabetic foot ulcer (CDC). Diabetic neuropathy reduces the sensation of touch, which makes it difficult for patients to feel damage. Peripheral vascular disease also lowers blood supply to the feet, thereby resulting in a delay in the healing process. Growing incidence of diabetes and awareness of diabetic foot ulcers is likely to boost demand for hyperbaric oxygen therapy devices. These devices can be used to treat chronic wounds in diabetes patients with poor response to traditional care. Hyperbaric oxygen therapy assists in healing wounds by increasing the amount of oxygen delivered to the damaged tissues, which accelerates the healing process. Therefore, the burden of diabetes and the ensuing diabetic foot ulcers generate a need for hyperbaric oxygen therapy devices in hospitals and wound care facilities, hence contributing to market expansion.
  
• Rising Healthcare Expenditure and Investment in Advanced Medical Equipment: One of the key driving factors for the hyperbaric oxygen therapy devices market is the rising healthcare expenditure and government help for the construction of healthcare infrastructure. Hospitals and specialty clinics have more cash to invest in revolutionary medical technologies. According to the Centers for Medicare & Medicaid Services (CMS), US healthcare spending will reach $5.3 trillion in 2024, up 7.2% from a year ago to 18.0% of GDP. Moreover, CMS’s 2025 National Health Expenditure Projection predicts that overall healthcare spending and hospital spending in particular is projected to increase by 6.8% in 2025. Higher government healthcare spending also facilitates infrastructure development in emerging economies as well. For instance, in the Union Budget 2025-26, the Government of India has allotted around ₹99,858 crore (US$11.6 billion) to the Ministry of Health and Family Welfare for healthcare services, infrastructure, medical education, and other health-sector spending. This means that today, healthcare facilities have access to more sophisticated and expensive equipment such as monoplace and multiplace hyperbaric oxygen chambers, which require highly specialized pressure control systems, oxygen supply chains, monitoring equipment and patient safety devices. Hence, the increase in the national healthcare budget and the development of hospital infrastructure are beneficial to the investment in modern medical technology, such as HBO therapy equipment.
  

What are the Major Advances Changing the Hyperbaric Oxygen Therapy Devices Market Today?

• AI-enabled and Data-driven HBOT: AI-enabled and data-driven hyperbaric oxygen therapy (HBOT) is set to become a disruptive force in the market as manufacturers seek to turn traditional pressure chambers into connected, smart devices that provide a personalized approach to the treatment. The latter is enabled by the ability of such devices to interpret physiological data and adjust the therapy in real time in order to ensure the best outcomes for each patient. One the 2025 patent applications reveals that a multifunctional HBOT system would utilize built-in physiological parameter diagnostics, remote data transmission, and AI-assisted treatment planning in order to personalize the care and continuously adapt to the needs of the patient, as determined by the medical staff. The innovation described in the patent could enable manufacturers to offer more valuable products to their clients, including the continuous remote monitoring of patients, automated adjustment of the oxygen parameters, remote physician control, data-driven treatment modification, and personalized treatment protocols. For instance, the AI-assisted treatment planning could be utilized in the analysis of the collected data in order to determine whether there is a need to alter the oxygen parameters or intervene in the treatment in case of an emergency. The 2025 patent showcases how such an innovation could be implemented by introducing automatic control of oxygen, CO2, and safety parameters, as well as alarms and remote data transmission. Such a technological level would enable manufacturers to differentiate their high-end hyperbaric oxygen therapy equipment on the market by focusing on the capabilities of the technology rather than the mechanics of the chamber. While the fully autonomous HBOT systems controlled by AI are a futuristic concept that is yet to gain regulatory approval and clinical acceptance, the shift toward data-driven HBOT therapy will undeniably impact the industry in years to come, enabling manufacturers to create more intelligent and safer devices.
  
• Enhanced Digital Connectivity and Remote Monitoring: The growing usage of digitally connected solutions and remote monitoring capabilities is one of the important factors influencing the development of the Hyperbaric Oxygen Therapy Devices Market. This growth driver motivates manufacturers to install digital control systems, sensors, communication modules, and other linked technologies in hyperbaric oxygen treatment (HBOT) chambers. Such solutions enable ongoing monitoring of pressure levels in the chamber, oxygen and carbon dioxide concentrations, temperature, humidity and other essential data. In addition, clinicians can use digital displays to monitor treatment compliance and take appropriate action in case of any deviations. For example, FDA-approved hyperbaric chamber models include touchscreens and CCTV cameras together with gas analysis devices, alarm systems, and digital technology to control the treatment procedure. Moreover, the increasing adoption of remote patient monitoring technology enables clinicians to capture crucial data and conduct telemedicine consultations without entering the hyperbaric chamber. For example, DanMedical's D-MAS HyperSat brand offers hyperbaric patient monitoring solutions that can communicate information about the conditions inside the chamber directly to the clinicians on board. The system uses live video, audio and text messaging to enable consultations between patients and professionals who are remote. Thus, digital HBOT management solutions might be advantageous in terms of storing and analyzing patient data, planning treatments, maintaining the equipment, establishing digital links with patients, etc. Indeed, the present indication is particularly strong given the fact that patient monitoring is a fundamental feature of any hyperbaric oxygen therapy. The U.S. FDA in August 2025 issued a warning based on many instances of injuries and deaths, highlighting the necessity of careful patient observation during HBO treatments. Connected systems also help in gathering patient data so that prompt intervention can be made and quality of care may be assured. Besides, such solutions make it possible to have remote consultations with specialists, track the treatment process, document and service equipment. With the increasing focus on linked medical devices and digital patient engagement in hospital networks and surgical centers, the increased use of remote technologies and digital displays is expected to assist the market expansion in the approaching years.
  

Category Wise Insights

By Product

Why Monoplace HBOT devices Hold a Prominent Position in the Market?

The Monoplace HBOT devices segment represented the highest revenue share in 2025 of 62%. The main reason behind this is the relative easiness and low cost of monoplace designs. They usually treat one patient at a time and are smaller in size and scale. They also require fewer professional staff and resources. Another factor is the rise of the outpatient wound-care and specialty treatment center industry.

Monoplace hyperbaric chambers are ideal for such facilities as they can provide the necessary treatment without the need to invest in a larger multiplace chamber. The need for treatments of selected types of non-healing wounds, such as diabetic foot syndrome, is also driving the market growth, as healthcare institutions seek to manage chronic diseases.

The Multiplace HBOT devices segment is growing at a highest CAGR during the projected period. The key reason behind this is that more patients can be treated at an increased rate. Compared to monoplace chambers, the multiplace chamber allows treating several patients at once, which makes it a more advantageous choice for large hospitals, trauma stations, and hyperbaric treatment centers that have a high occupancy rate. Moreover, such equipment enables simultaneous treatment of patients in attendance of trained medical staff in the chamber, which is useful for those needing intensive care or supervision.

By Application

Why Wound Healing Capture the Highest Market Share in the Hyperbaric Oxygen Therapy Devices Market?

The wound healing segment would have the highest share of the market in 2025 of 39.6%. The main reason for the growth in this field is the use of HBOT for complicated diabetic foot wounds, as well as other serious wounds, which do not respond to conventional therapies. One of the ways of hyperbaric oxygen therapy is to increase the amount of oxygen in the tissues, which promotes the healing of wounds. According to the Medicare program in the United States, hyperbaric oxygen therapy is covered for diabetic lower extremity wounds when the beneficiary has type 1 or type 2 diabetes, and the wound is graded as Wagner III or higher following the Wagner classification system, which is applied in the lower limb, after an unsuccessful attempt of standard wound care.

The infection treatment segment is growing at a fastest rate over the projected period. The major indication for growth is the use of HBOT in association with antibiotics and surgery for selected serious infections. The conditions are necrotizing soft-tissue infections, clostridial myositis/myonecrosis (gas gangrene), osteomyelitis that is considered refractory to conventional therapy, and intracranial abscess.

These conditions are among the approved indications of the Undersea and Hyperbaric Medical Society (UHMS). Hyperbaric oxygen therapy can promote the healing of infected and ischemic tissues by increasing the oxygen supply to the affected areas. Hypoxia decreases the function of white blood cells, and in the case of necrotizing soft tissue infections, UHMS recommends using HBOT to increase the oxygen supply to the ischemic tissue and reduce hypoxic leukocyte dysfunction. Moreover, there is evidence that HBOT can enhance the antibacterial activity of certain antibiotics when used in combination with appropriate antimicrobial therapy.

Regional Analysis

How Big is North America Hyperbaric Oxygen Therapy Devices Market Size?

Its market size, in terms of North America hyperbaric oxygen therapy devices, is projected to be USD 1.24 billion in 2025 with a growth of about USD 1.95 billion in 2035 with a CAGR of 4.6% between 2026 and 2035.

To learn more about this report - request a sample report PDF

Why did North America Dominate the Hyperbaric Oxygen Therapy Devices Market in 2025?

In 2025, North America will dominate the global market with an estimated market share of 32%. The growth is owing to the high prevalence of diabetes. For instance, according to the American Diabetes Association, over 40 million Americans, or 12% of the population, are living with diabetes in which over 2 million Americans are living with type 1 diabetes, including about 314,000 children and adolescents.

Canada Hyperbaric Oxygen Therapy Devices Market Trends

Canada captures a highest market share. The key driver of the market is the rising healthcare expenditure in Canada. According to the Canadian Institute for Health Information (CIHI), the country’s healthcare spending is expected to hit CAD C$399 billion (about US$290 billion) by 2025, a 4.2% increase from 2024. Hospital spending is forecasted to climb 4.0% in 2025. Public sectors make up about 71.2% of healthcare spending. Hence, higher spending might be advantageous to hospitals and specialist clinics by obtaining technologically advanced equipment, such as HBOT devices.

Why is Europe Growing at a Significant Rate in the Hyperbaric Oxygen Therapy Devices Market?

Europe is growing at a significant rate. The high and growing incidence of diabetes in Europe is a major driver of the industry. According to the IDF Diabetes Atlas 2025, 65.6 million adults aged 20–79 years were living with diabetes in Europe in 2024, which is 9.8% of the adult population. Furthermore, the survey claimed that diabetes affects 34% of the European population with 34% of cases undiagnosed. In 2024, diabetes care costs in Europe stood at around US$192.9 billion.

Moreover, the huge diabetic population greatly raises the chance of developing related illnesses such as diabetic foot ulcers and other hard-to-heal wounds. Diabetes can cause poor circulation and nerve damage which causes wounds to heal slowly. Hyperbaric oxygen therapy is utilized as an adjuvant treatment for certain severe or recurrent wounds that are unresponsive to standard therapies. Consequently, the hyperbaric treatment facilities and the hospitals using hyperbaric chambers for diabetic wound care are anticipated to increase.

UK Hyperbaric Oxygen Therapy Devices Market Trends

UK holds a prominent revenue share. The strength of the UK’s HBOT ecosystem is underscored by the number of specialized treatment and research facilities. According to the British Hyperbaric Association, there is a list of established hyperbaric treatment entities in the United Kingdom, such as Aberdeen Royal Infirmary, DDRC Healthcare in Plymouth, St Richard’s Hospital in Chichester, James Paget University Hospital, Whipps Cross University Hospital, Midlands Diving Chamber, the North of England Medical Hyperbaric Unit, and other organizations. Additionally, NHS England states that it purchases hyperbaric oxygen therapy from 7 independent sector providers at 8 centers, spending about £8.2 million in the financial year 2023/24.

Why is the Asia Pacific is growing at the highest CAGR in the Hyperbaric Oxygen Therapy Devices Market?

The Asia Pacific is expected to grow at the highest CAGR during the projected period. The growth contributor is medical tourism and related specialized services. Such Asian countries as Thailand and other neighboring states are witnessing an increase in demand for private medical services and hyperbaric facilities.

India Hyperbaric Oxygen Therapy Devices Market Trends

India holds a prominent market share in 2025. A critical driving force for the HBOT market growth is the increasing availability of specialty hyperbaric treatment centers in metro and tier-2 cities. In addition to the rising awareness among medical professionals and patients, HBOT is being increasingly adopted as an adjuvant therapy for managing select refractory wounds, infections, and other indications.

The combination of a high incidence of chronic diseases, an increase in healthcare spending, and the rising number of private hospitals, along with the growing awareness of hyperbaric oxygen therapy, and the availability of hyperbaric treatment centers will propel the growth of the India HBOT devices market.

Why is the Middle East & Africa Region is growing rapidly in the Hyperbaric Oxygen Therapy Devices?

MEA is growing rapidly. The market is propelled by increasing healthcare expenditure, hospital infrastructure modernization and increased prevalence of chronic diseases such as diabetes, leading to development of severe wounds and diabetic foot ulcers. In example, Gulf countries like Saudi Arabia and UAE spend extensively in sophisticated medical infrastructure and facilities for innovative kinds of healthcare treatment, presenting substantial potential opportunities for HBOT chambers.

UAE Hyperbaric Oxygen Therapy Devices Market Trends

UAE holds a prominent share in 2025. The growing healthcare expenditure and increasing prevalence of diabetes in the area.

Top Players in the Hyperbaric Oxygen Therapy Devices Market and Their Offerings

• Sechrist Industries Inc.
• Perry Baromedical Corporation
• Environmental Tectonics Corporation (ETC)
• HAUX-LIFE-SUPPORT GmbH
• Fink Engineering Pty Ltd.
• OxyHealth LLC / OxyHeal Health Group
• Gulf Coast Hyperbarics Inc.
• HEARMEC Co. Ltd.
• Hyperbaric SAC
• IHC Hytech B.V. / Royal IHC
• Hyperbaric Modular Systems (HMS)
• Pan America Hyperbarics, Inc.
• AHA Hyperbarics GmbH
• Tekna Manufacturing Inc.
• BioBarica
• BAROKS Hyperbaric
• OxyVal Hyperbaric
• OxyAir Hyperbaric Technology
• Hyperbaric Medical Solutions
• Airox Technologies Ltd.

Key Developments

Hyperbaric oxygen therapy devices market has experienced considerable changes in the last two years as the market players are trying to diversify their technological aspects and develop product portfolio using strategic approaches.

• In January 2024, US-based Sechrist Industries has unveiled two products, the eHEAL software system and the 3300HM Hyperbaric Chamber, to enhance hyperbaric medicine. The new offerings combine advanced technology with user-friendly features, aiming to improve the efficiency and safety of hyperbaric treatments.
  

These strategic measures have enabled the companies to reinforce their competitive positions, increase the product line, boost their technological competencies and also seize growth opportunities in the fast-growing hyperbaric oxygen therapy devices market.